5 Years Long Term Results After Standalone CyPass-Implantation
Retro- and Prospective Monocentric Study to Evaluate the Safety and Effectiveness of the CyPass Stent 5 Years After Implantation
研究概览
详细说明
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Mecklenburg/Vorpommern
-
Neubrandenburg、Mecklenburg/Vorpommern、德国、17036
- Dietrich-Bonhoeffer-Klinikum
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- patients who have undergone a standalone cypass implantation at least 3 years ago
- signed inform consent
Exclusion Criteria:
- Patients with too much travel distance between study center and home
- Patients who cannot visit the studycenter due to health problems
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
---|---|
standalone CyPass implantation
patients who have undergone a standalone cypass implantation without cataract surgery more than 3 years ago
|
Heidelberg Retinal Topography, Visual field, intraocular pressure, medication anamnesis, Retinal Nerve Fibre Layer Thickness, Pachymetry, Sonography, full ophthalmological examination
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Number of Patients That Achieve Target Intraocular Pressure Measured in mmHg
大体时间:up to 7 years
|
The Measurement of the intraocular Pressure is a criterion for the Efficacy of CyPass Stent Procedure (success rate).
The postoperative target pressure of 15 mmHg, 18 mmHg or 21 mmHg (depends on Glaucoma Status) has to be achieved.
|
up to 7 years
|
Change of Intraocular Pressure in mmHg Preoperatively (at Screening) vs Postoperatively (at Final Examination)
大体时间:up to 7 years
|
The Measurement of the intraocular Pressure change is a criterion for the Efficacy of CyPass Stent Procedure (success rate). The postoperative pressure after 5 to 7 years has to be compared with the preoperative intraocular pressure (in mmHg) The change was calculated only from two time points. (value at the final examination time point minus the value at the preoperative time point |
up to 7 years
|
Number of Additional Medication
大体时间:up to 7 years
|
The number of additional Glaucoma medication is another criterion to determine the Efficacy of CyPass Stent Procedure (success rate). Up to 4 different active substance can be used to reduce the pressure. The more substances the patient uses postoperatively the lower is the success after implantation of the CyPass-Stent. The postoperative number of medications after 5 years has to be compared with the preoperative number |
up to 7 years
|
Number of Participants With Secondary Glaucoma Procedures
大体时间:up to 7 years
|
To determine the efficacy of CyPass Stent procedure completely the number of secondary glaucoma interventions (surgery/ laser) has to be documented
|
up to 7 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Number of Participants With Stability of Optic Nerve
大体时间:up to 7 years
|
The Measurement of the optic nerve (HRT) in comparison to the baseline is needed to evaluate the glaucoma damage and to determine the Longterm success rate and the safety of the CyPass- Stent-Procedure. With papillary tomography you can see the changes in the optic nerve head concerning the permanent failures of retinal vessels , measure them very precisely and compare them with the previous findings. |
up to 7 years
|
Number of Participants With Stability of the Retinal Nerve Fiber Layer Thickness
大体时间:up to 7 years
|
The comparison of the preoperative and postoperative Status of the Retinal Nerve Fiber Layer Thickness and retinal fundus thickness is another criterion to determine the absolute and relative success.
|
up to 7 years
|
Number of Participants With Stability of Visual Field
大体时间:up to 7 years
|
The parameter of the Visual Field (Mean Deviation) will be measured to evaluate the Safety of the CyPass-Procedure.
The visual Field shows the progression of glaucoma defects concerning failures in different parts for example in the center or in the periphery of the visual field.
|
up to 7 years
|
Number of Participants With Stability of Stent Position
大体时间:up to 7 years
|
Determination of Stent Position in the angle will be performed to exclude moving of the Stent.
The stent could change it's position forward into the anterior chamber or backwards in the suprachorioidal space
|
up to 7 years
|
Number of Participants With Stability of Stent Tissue Interaction
大体时间:up to 7 years
|
Determination of iris tissue reaction to the stent will be performed.
We document slight reaction without involving the opening, iris reaction with involving the opening and complete closure by tissue.
The iris Tissue could overgrow the opening of the stent and therfore the function of the stent is disturbed or even failed.
|
up to 7 years
|
Number of Participants With Intra-and Postoperative Complications
大体时间:up to 7 years
|
The number of intra-and postoperative complications are needed to evaluate the safety of the CyPass-procedure
|
up to 7 years
|
Number of Participants With Suprachoroidal Bleb
大体时间:up to 7 years
|
The Determination of the suprachoroidal bleb is needed to evaluate the function of the stent and the efficacy of the procedure.
The bigger the bleb, the lower the pressure and the better the efficacy of the stent
|
up to 7 years
|
合作者和调查者
调查人员
- 首席研究员:Helmut Hoeh, MD,FEBO、Department of Ophthalmology, Neubrandenburg, Germany
出版物和有用的链接
一般刊物
- Garcia-Feijoo J, Rau M, Grisanti S, Grisanti S, Hoh H, Erb C, Guguchkova P, Ahmed I, Grabner G, Reitsamer H, Shaarawy T, Ianchulev T. Supraciliary Micro-stent Implantation for Open-Angle Glaucoma Failing Topical Therapy: 1-Year Results of a Multicenter Study. Am J Ophthalmol. 2015 Jun;159(6):1075-1081.e1. doi: 10.1016/j.ajo.2015.02.018. Epub 2015 Mar 3.
- Hoeh H, Vold SD, Ahmed IK, Anton A, Rau M, Singh K, Chang DF, Shingleton BJ, Ianchulev T. Initial Clinical Experience With the CyPass Micro-Stent: Safety and Surgical Outcomes of a Novel Supraciliary Microstent. J Glaucoma. 2016 Jan;25(1):106-12. doi: 10.1097/IJG.0000000000000134.
- Grisanti S, Margolina E, Hoeh H, Rau M, Erb C, Kersten-Gomez I, Dick HB, Grisanti S. [Supraciliary microstent for open-angle glaucoma: clinical results of a prospective multicenter study]. Ophthalmologe. 2014 Jun;111(6):548-52. doi: 10.1007/s00347-013-2927-6. German.
- Hoh H, Grisanti S, Grisanti S, Rau M, Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd. 2014 Apr;231(4):377-81. doi: 10.1055/s-0034-1368214. Epub 2014 Apr 25.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Glaucoma diagnostics的临床试验
-
Stanford UniversitySanta Clara Valley Medical Center撤销
-
McMaster UniversityMerck Frosst Canada Ltd.; Public Health Agency of Canada (PHAC); Juravinski Cancer Centre Foundation未知
-
Haukeland University HospitalSiemens Corporation, Corporate Technology招聘中
-
Center for Eye Research AustraliaNovartis Pharmaceuticals终止
-
Hanyang University Seoul HospitalSeegene Medical Foundation完全的